SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES

Scope & Guideline

Exploring the Complexities of Respiratory Diseases

Introduction

Welcome to the SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1124-0490
PublisherMATTIOLI 1885
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1996 to 2024
AbbreviationSARCOIDOSIS VASC DIF / Sarcoidosis Vasc. Diffus. Lung Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA DELLA LODESANA 649-SX, FIDENZA 43046 PR, ITALY

Aims and Scopes

The journal 'Sarcoidosis, Vasculitis and Diffuse Lung Diseases' is dedicated to advancing the understanding and treatment of sarcoidosis and related conditions, with an emphasis on clinical research, diagnostics, and therapeutic strategies.
  1. Clinical Research on Sarcoidosis:
    The journal focuses on clinical studies that investigate the epidemiology, pathophysiology, and treatment outcomes of sarcoidosis, providing insights into patient management and care.
  2. Vasculitis and Interstitial Lung Diseases:
    It includes research on various forms of vasculitis and interstitial lung diseases, highlighting their clinical implications and management.
  3. Diagnostic Techniques and Biomarkers:
    The journal emphasizes the development and validation of diagnostic techniques and biomarkers for sarcoidosis and related conditions, improving diagnostic accuracy and patient monitoring.
  4. Prognostic Factors and Treatment Efficacy:
    Research on prognostic factors that influence treatment outcomes and the efficacy of various therapeutic agents in sarcoidosis and lung diseases is a core focus.
  5. Multidisciplinary Approaches:
    The journal encourages studies that adopt multidisciplinary approaches to understand the complex interactions of sarcoidosis with other diseases, enhancing holistic patient care.
Recent publications in 'Sarcoidosis, Vasculitis and Diffuse Lung Diseases' reflect evolving trends and emerging themes that are gaining traction in the field.
  1. Impact of COVID-19 on Sarcoidosis Patients:
    There is a growing focus on understanding the effects of COVID-19 on patients with sarcoidosis, particularly the implications for disease management and outcomes following infection.
  2. Integration of Telehealth and Remote Monitoring:
    The emergence of telehealth solutions and remote monitoring technologies for managing sarcoidosis and interstitial lung diseases has become a significant area of interest.
  3. Multimorbidity and Comorbid Conditions:
    Research exploring the interplay between sarcoidosis and other comorbid conditions, such as cardiovascular diseases and mental health issues, is increasingly prominent, highlighting the need for comprehensive care.
  4. Use of Advanced Imaging Techniques:
    There is an upward trend in studies utilizing advanced imaging techniques, such as high-resolution computed tomography, to assess disease progression and treatment response in sarcoidosis.
  5. Personalized Medicine Approaches:
    An emerging theme is the exploration of personalized medicine in sarcoidosis treatment, focusing on tailoring therapies based on individual patient characteristics and disease profiles.

Declining or Waning

While the journal has maintained a robust focus on sarcoidosis and related lung diseases, certain areas appear to be declining in prominence within recent publications.
  1. Case Reports of Rare Manifestations:
    There has been a noticeable decline in the publication of case reports detailing rare manifestations of sarcoidosis, suggesting a shift towards more generalizable research findings.
  2. Basic Science Studies:
    Research focused on the basic science aspects of sarcoidosis, such as cellular and molecular mechanisms, has seen decreased representation, indicating a preference for clinical and translational studies.
  3. Longitudinal Studies on Historical Data:
    Longitudinal studies utilizing historical data for sarcoidosis outcomes are less frequently published, possibly reflecting a trend towards more contemporary, real-time data analysis.

Similar Journals

Current Pulmonology Reports

Unveiling breakthroughs in respiratory disease management.
Publisher: SPRINGERISSN: Frequency: 4 issues/year

Current Pulmonology Reports, published by SPRINGER, stands as a vital resource in the realm of respiratory health, delivering peer-reviewed research that informs clinical practices and advances understanding within the field of pulmonology. With an E-ISSN of 2199-2428, this journal captures the latest findings and technological innovations pertinent to respiratory diseases, treatment protocols, and patient management strategies. Although currently classified as non-open access, it ensures robust dissemination of significant research contributions which are essential for professionals and scholars alike. The journal's objective is not only to foster a deeper understanding of lung health issues but also to bridge the gap between research and application, thereby impacting real-world practices. As the demand for comprehensive studies in pulmonology continues to grow, Current Pulmonology Reports seeks to maintain its position as a premier outlet for quality research, ultimately bettering outcomes in respiratory medicine.

Indian Journal of Rheumatology

Advancing knowledge in rheumatology, one article at a time.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

JOURNAL OF NEPHROLOGY

Empowering professionals with cutting-edge nephrology research.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.

JOURNAL OF CLINICAL INVESTIGATION

Innovating healthcare solutions with groundbreaking research.
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: 0021-9738Frequency: 12 issues/year

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

ANNALS OF CLINICAL AND LABORATORY SCIENCE

Innovating Diagnostic Practices Through Peer Review
Publisher: ASSOC CLINICAL SCIENTISTSISSN: 0091-7370Frequency: 6 issues/year

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

Pulmonology

Connecting theory to practice in the dynamic world of lung health.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Elevating Clinical and Experimental Ophthalmology
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Internal Medicine

Unveiling the Nuances of Internal Medicine
Publisher: JAPAN SOC INTERNAL MEDICINEISSN: 0918-2918Frequency: 12 issues/year

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

INFECTION

Shaping the Future of Infectious Disease Research
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Lancet Respiratory Medicine

Exploring new horizons in respiratory medicine.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.